Smith Chas P & Associates PA Cpas Has $49.44 Million Stock Holdings in UnitedHealth Group Incorporated (NYSE:UNH)

Smith Chas P & Associates PA Cpas lifted its holdings in UnitedHealth Group Incorporated (NYSE:UNH) by 0.4% in the 4th quarter, according to its most recent 13F filing with the SEC. The firm owned 97,736 shares of the healthcare conglomerate’s stock after purchasing an additional 376 shares during the quarter. UnitedHealth Group comprises 2.8% of Smith Chas P & Associates PA Cpas’ holdings, making the stock its 10th biggest position. Smith Chas P & Associates PA Cpas’ holdings in UnitedHealth Group were worth $49,441,000 as of its most recent SEC filing.

Several other institutional investors and hedge funds also recently made changes to their positions in UNH. AlphaMark Advisors LLC bought a new stake in UnitedHealth Group during the fourth quarter worth about $30,000. Tran Capital Management L.P. grew its stake in UnitedHealth Group by 3.0% in the 4th quarter. Tran Capital Management L.P. now owns 19,875 shares of the healthcare conglomerate’s stock valued at $10,054,000 after buying an additional 575 shares during the last quarter. Olstein Capital Management L.P. boosted its stake in UnitedHealth Group by 26.7% in the 4th quarter. Olstein Capital Management L.P. now owns 15,200 shares of the healthcare conglomerate’s stock valued at $7,689,000 after purchasing an additional 3,200 shares during the period. Flagship Harbor Advisors LLC increased its holdings in shares of UnitedHealth Group by 3.9% during the fourth quarter. Flagship Harbor Advisors LLC now owns 7,139 shares of the healthcare conglomerate’s stock worth $3,611,000 after purchasing an additional 267 shares during the period. Finally, Insight Inv LLC raised its stake in UnitedHealth Group by 100.7% in the fourth quarter. Insight Inv LLC now owns 303 shares of the healthcare conglomerate’s stock valued at $153,000 after purchasing an additional 152 shares in the last quarter. Institutional investors and hedge funds own 87.86% of the company’s stock.

Insider Buying and Selling at UnitedHealth Group

In related news, Director Timothy Patrick Flynn bought 1,000 shares of the company’s stock in a transaction dated Friday, January 17th. The shares were bought at an average price of $511.57 per share, for a total transaction of $511,570.00. Following the completion of the acquisition, the director now directly owns 4,500 shares of the company’s stock, valued at $2,302,065. This trade represents a 28.57 % increase in their ownership of the stock. The acquisition was disclosed in a legal filing with the SEC, which can be accessed through this link. 0.33% of the stock is currently owned by company insiders.

UnitedHealth Group Trading Up 0.5 %

Shares of UNH stock opened at $532.26 on Friday. The company has a market cap of $489.83 billion, a P/E ratio of 34.34, a PEG ratio of 1.41 and a beta of 0.62. UnitedHealth Group Incorporated has a fifty-two week low of $436.38 and a fifty-two week high of $630.73. The stock has a 50 day simple moving average of $541.04 and a two-hundred day simple moving average of $563.84. The company has a debt-to-equity ratio of 0.74, a quick ratio of 0.91 and a current ratio of 0.83.

UnitedHealth Group (NYSE:UNH) last posted its quarterly earnings results on Thursday, January 16th. The healthcare conglomerate reported $6.81 EPS for the quarter, topping analysts’ consensus estimates of $6.74 by $0.07. The business had revenue of $100.81 billion during the quarter, compared to analysts’ expectations of $101.60 billion. UnitedHealth Group had a net margin of 3.60% and a return on equity of 26.69%. The business’s quarterly revenue was up 6.8% on a year-over-year basis. During the same period last year, the company posted $5.83 earnings per share. Research analysts forecast that UnitedHealth Group Incorporated will post 29.74 earnings per share for the current year.

UnitedHealth Group Dividend Announcement

The company also recently announced a quarterly dividend, which was paid on Tuesday, December 17th. Investors of record on Monday, December 9th were issued a $2.10 dividend. This represents a $8.40 dividend on an annualized basis and a dividend yield of 1.58%. The ex-dividend date of this dividend was Monday, December 9th. UnitedHealth Group’s dividend payout ratio is currently 54.19%.

Wall Street Analysts Forecast Growth

Several brokerages recently weighed in on UNH. Bank of America dropped their price objective on UnitedHealth Group from $675.00 to $650.00 and set a “buy” rating for the company in a research report on Wednesday, October 16th. UBS Group decreased their price target on shares of UnitedHealth Group from $680.00 to $650.00 and set a “buy” rating on the stock in a report on Wednesday, October 16th. HSBC upgraded shares of UnitedHealth Group from a “hold” rating to a “buy” rating and set a $595.00 target price on the stock in a research report on Friday, January 10th. Piper Sandler dropped their price target on UnitedHealth Group from $605.00 to $600.00 and set an “overweight” rating for the company in a research note on Thursday, January 2nd. Finally, Hsbc Global Res raised UnitedHealth Group from a “hold” rating to a “strong-buy” rating in a report on Friday, January 10th. One equities research analyst has rated the stock with a hold rating, twenty have given a buy rating and two have issued a strong buy rating to the company’s stock. Based on data from MarketBeat.com, UnitedHealth Group has a consensus rating of “Buy” and a consensus price target of $627.74.

About UnitedHealth Group

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.